Advertisement
Product › Details
MD1003 (high-dose D-biotin, MedDay)
Next higher product group | MS DRUGS | |
Status | 2014-11-24 development p3 existent | |
Organisation | MedDay Pharmaceuticals S.A.S. | |
Record changed: 2023-07-10 |
Advertisement
More documents for MS DRUGS
- [1] Reuters. (6/1/21). "News: Novartis Signs Deal that Could Lead to Acquisition of Zurich Start-up Cellerys"....
- [2] Sanofi S.A.. (9/28/20). "Press Release: Sanofi Completes Principia Biopharma Inc. Acquisition. Principia Biopharma Inc. Is Now a Wholly Owned Subsidiary of Sanofi". Paris....
- [3] Sanofi S.A.. (8/17/20). "Press Release: Sanofi to Acquire Principia Biopharma". Paris & South San Francisco, CA....
- [4] Cyxone AB. (5/20/20). "Press Release: Dr Tara Heitner Appointed New CEO for Cyxone"....
- [5] MedDay Pharmaceuticals S.A.S.. (3/10/20). "Press Release: MedDay Reports Top-line Data from Phase III Trial »SPI2« for Treatment of Progressive Forms of Multiple Sclerosis". Paris....
- [6] Edinburgh Innovations. (2/17/20). "Press Release: Spinout Takes Aim at Treatments for Multiple Sclerosis"....
- [7] Novartis AG. (4/24/19). "Press Release: Novartis Starts 2019 with Strong Sales and Double Digit Core Operating Income Growth, Mayzent Launch and Alcon Spin-off, Profit Guidance Upgraded". Basel....
- [8] Immunic, Inc.. (4/12/19). "Press Release: Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases". San Diego, CA & Martinsried....
- [9] Lonza Group AG. (2/13/19). "Press Release: Emerald Health Pharmaceuticals and Lonza Announce Agreement for Manufacturing of Novel Cannabinoid-Derived Drug Candidate". San Diego, CA & Basel....
- [10] Rewind Therapeutics. (2/6/19). "Press Release: Rewind Therapeutics Expands Scientific Advisory Board with Addition of Professors Robin Franklin and Catherine Lubetzki, Bringing further Expertise in Myelin and Multiple Sclerosis Research". Leuven....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top